Challenges to the development of vaccines to hepatitis C virus that elicit neutralizing antibodies.
Despite 20 years of research, a vaccine to prevent hepatitis C virus (HCV) infection has not been developed. A vaccine to prevent HCV will need to induce broadly reactive immunity able to prevent infection by the 7 genetically and antigenically distinct genotypes circulating world-wide. Hepatitis C...
Main Author: | Heidi Edelgard Drummer |
---|---|
Format: | Article |
Language: | English |
Published: |
Frontiers Media S.A.
2014-07-01
|
Series: | Frontiers in Microbiology |
Subjects: | |
Online Access: | http://journal.frontiersin.org/Journal/10.3389/fmicb.2014.00329/full |
Similar Items
-
Quaternary Interaction of the HIV-1 Envelope Trimer with CD4 and Neutralizing Antibodies
by: Qingbo Liu, et al.
Published: (2021-07-01) -
Research progress on neutralizing epitopes and antibodies for the Rabies virus
by: Chenjuan Shi, et al.
Published: (2022-12-01) -
CD81 and Hepatitis C Virus (HCV) Infection
by: Lucie Fénéant, et al.
Published: (2014-02-01) -
Polymorphic Forms of Human Cytomegalovirus Glycoprotein O Protect against Neutralization of Fibroblast Entry by Antibodies Targeting Epitopes Defined by Glycoproteins H and L
by: Li He, et al.
Published: (2022-07-01) -
Current Hepatitis C Vaccine Candidates Based on the Induction of Neutralizing Antibodies
by: Elsa Gomez-Escobar, et al.
Published: (2023-05-01)